Who Paid My Doc
Interstim
Device Sacral Nerve Stimulation
PDI 00613994913654
General payments
$8,393,203
Research payments
$3,099,037
Through program year 2025, $8,393,203 in general payments and $3,099,037 in research payments were reported against Interstim (Sacral Nerve Stimulation).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
10 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $1,720,592 | 18,083 |
| 2025 | Research | $649,788 | 162 |
| 2024 | General | $1,860,891 | 20,635 |
| 2024 | Research | $438,406 | 102 |
| 2023 | General | $1,831,177 | 21,100 |
| 2023 | Research | $556,437 | 161 |
| 2022 | General | $2,059,859 | 18,709 |
| 2022 | Research | $727,036 | 173 |
| 2021 | General | $920,684 | 9,783 |
| 2021 | Research | $727,369 | 189 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 85 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 52 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
88,310 general · 787 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.